Ribosomal DNA methylation in patients with endometrial carcinoma: An independent prognostic marker

Cancer

Volumn 94, Issue 11, 2002, Pages 2941-2952

  Powell, Matthew A ^a   Mutch, David G ^a   Rader, Janet S ^a   Herzog, Thomas J ^a   Huang, Tim Hui Ming ^a,b   Goodfellow, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Missouri   (United States)

Author keywords

Endometrial carcinoma; Molecular marker; Prognosis; Ribosomal DNA methylation

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; DIAGNOSTIC VALUE; DNA METHYLATION; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; CARCINOMA, ENDOMETRIOID; CYSTADENOCARCINOMA, PAPILLARY; DNA METHYLATION; DNA, NEOPLASM; DNA, RIBOSOMAL; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036604045     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10559     Document Type: Article

References (26)

1. Cancer statistics, 2000
2. Race and clinical outcome in endometrial carcinoma
3. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
4. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers
5. Global DNA hypomethylation in breast carcinoma: Correlation with prognostic factors and tumor progression
6. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in Stage I non-small-cell lung cancer
7. Inactivation of the DNA-repair gene MGMTand the clinical response of gliomas to alkylating agents
8. Hypermethylation of ribosomal DNA in human breast carcinoma
9. Clinical significance of microsatellite instability in endometrial carcinoma
10. Mosaic methylation of the repeat unit of the human ribosomal RNA genes
11. Nonparametric estimation from incomplete observations
12. Evaluation of survival data and two rank order statistics arising in its consideration
13. Annual report on the results of treatment in gynecological cancer
14. A Phase III randornized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma
15. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers
16. Microsatellite instability is an independent indicator of recurrence in sporadic Stage I-II endometrial adenocarcinoma
17. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas
18. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
19. The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists
20. High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer
21. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: A multivariate analysis
22. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: A comparison of complication rates
23. Tumor size in endometrial cancer: A prognostic factor for lymph node metastasis
24. Racial differences in surgically staged patients with endometrial cancer
25. Impact of ethnicity on the incidence of high-risk endometrial carcinoma
26. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers